APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurorehabilitation Biofeedback Therapy Device

Compare research editions
View pricing & licenses

Selected research

Industry Research

Neurorehabilitation Biofeedback Therapy Device Industry Research Report 2026

24 December 2025129 pages

Choose your research edition.

Industry ResearchNeurorehabilitation Biofeedback Therapy Device Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurorehabilitation Biofeedback Therapy Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Neurorehabilitation Biofeedback Therapy Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurorehabilitation Biofeedback Therapy Device Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurorehabilitation Biofeedback Therapy Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Neurorehabilitation Biofeedback Therapy Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Neurorehabilitation Biofeedback Therapy Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Neurorehabilitation Biofeedback Therapy Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Neurorehabilitation Biofeedback Therapy Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Neurorehabilitation Biofeedback Therapy Device include Abbott, ARKRAY, Ascensia, B. Braun, BIONIME, GMMC Group, LIANFA, Lifescan and Lobeck Medical AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Neurorehabilitation Biofeedback Therapy Device market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Neurorehabilitation Biofeedback Therapy Device Market by Company

Abbott

ARKRAY

Ascensia

B. Braun

BIONIME

GMMC Group

LIANFA

Lifescan

Lobeck Medical AG

Sinocare

TERUMO

Roche

Neurorehabilitation Biofeedback Therapy Device Segment by Type

Conventional

Intelligent

Neurorehabilitation Biofeedback Therapy Device Segment by Application

Hospital

Clinic

Others

Neurorehabilitation Biofeedback Therapy Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation Biofeedback Therapy Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation Biofeedback Therapy Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation Biofeedback Therapy Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Neurorehabilitation Biofeedback Therapy Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Neurorehabilitation Biofeedback Therapy Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Neurorehabilitation Biofeedback Therapy Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Neurorehabilitation Biofeedback Therapy Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Neurorehabilitation Biofeedback Therapy Device Sales (Units) of Manufacturers (2021-2026) Table 7. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Manufacturers (2021-2026) Table 8. Global Neurorehabilitation Biofeedback Therapy Device Revenue of Manufacturers (2021-2026) Table 9. Global Neurorehabilitation Biofeedback Therapy Device Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Neurorehabilitation Biofeedback Therapy Device Average Price (K US$/Unit) of Manufacturers (2021-2026) Table 11. Global Neurorehabilitation Biofeedback Therapy Device Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Neurorehabilitation Biofeedback Therapy Device, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Neurorehabilitation Biofeedback Therapy Device, Product Type & Application Table 14. Global Neurorehabilitation Biofeedback Therapy Device Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Neurorehabilitation Biofeedback Therapy Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Company Information Table 19. Abbott Business Overview Table 20. Abbott Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 21. Abbott Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 22. Abbott Recent Developments Table 23. ARKRAY Company Information Table 24. ARKRAY Business Overview Table 25. ARKRAY Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 26. ARKRAY Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 27. ARKRAY Recent Developments Table 28. Ascensia Company Information Table 29. Ascensia Business Overview Table 30. Ascensia Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 31. Ascensia Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 32. Ascensia Recent Developments Table 33. B. Braun Company Information Table 34. B. Braun Business Overview Table 35. B. Braun Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 36. B. Braun Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 37. B. Braun Recent Developments Table 38. BIONIME Company Information Table 39. BIONIME Business Overview Table 40. BIONIME Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 41. BIONIME Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 42. BIONIME Recent Developments Table 43. GMMC Group Company Information Table 44. GMMC Group Business Overview Table 45. GMMC Group Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 46. GMMC Group Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 47. GMMC Group Recent Developments Table 48. LIANFA Company Information Table 49. LIANFA Business Overview Table 50. LIANFA Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 51. LIANFA Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 52. LIANFA Recent Developments Table 53. Lifescan Company Information Table 54. Lifescan Business Overview Table 55. Lifescan Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 56. Lifescan Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 57. Lifescan Recent Developments Table 58. Lobeck Medical AG Company Information Table 59. Lobeck Medical AG Business Overview Table 60. Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 61. Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 62. Lobeck Medical AG Recent Developments Table 63. Sinocare Company Information Table 64. Sinocare Business Overview Table 65. Sinocare Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 66. Sinocare Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 67. Sinocare Recent Developments Table 68. TERUMO Company Information Table 69. TERUMO Business Overview Table 70. TERUMO Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 71. TERUMO Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 72. TERUMO Recent Developments Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Neurorehabilitation Biofeedback Therapy Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 76. Roche Neurorehabilitation Biofeedback Therapy Device Product Portfolio Table 77. Roche Recent Developments Table 78. Global Neurorehabilitation Biofeedback Therapy Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Neurorehabilitation Biofeedback Therapy Device Sales by Region (2021-2026) & (Units) Table 80. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Region (2021-2026) Table 81. Global Neurorehabilitation Biofeedback Therapy Device Sales by Region (2027-2032) & (Units) Table 82. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Region (2027-2032) Table 83. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2021-2026) Table 85. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Region (2027-2032) Table 87. North America Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 89. North America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 90. North America Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 94. Europe Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 95. Europe Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 99. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 100. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 104. South America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 105. South America Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2026) & (Units) Table 109. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales by Country (2027-2032) & (Units) Table 110. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2026) & (Units) Table 113. Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2027-2032) & (Units) Table 114. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2026) Table 115. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2027-2032) Table 116. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2026) Table 119. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2027-2032) Table 120. Global Neurorehabilitation Biofeedback Therapy Device Price by Type (2021-2026) & (K US$/Unit) Table 121. Global Neurorehabilitation Biofeedback Therapy Device Price by Type (2027-2032) & (K US$/Unit) Table 122. Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2026) & (Units) Table 123. Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2027-2032) & (Units) Table 124. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2026) Table 125. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2027-2032) Table 126. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2026) Table 129. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2027-2032) Table 130. Global Neurorehabilitation Biofeedback Therapy Device Price by Application (2021-2026) & (K US$/Unit) Table 131. Global Neurorehabilitation Biofeedback Therapy Device Price by Application (2027-2032) & (K US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Neurorehabilitation Biofeedback Therapy Device Distributors List Table 135. Neurorehabilitation Biofeedback Therapy Device Customers List Table 136. Neurorehabilitation Biofeedback Therapy Device Industry Trends Table 137. Neurorehabilitation Biofeedback Therapy Device Industry Drivers Table 138. Neurorehabilitation Biofeedback Therapy Device Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Neurorehabilitation Biofeedback Therapy Device Product Image Figure 5. Global Neurorehabilitation Biofeedback Therapy Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Neurorehabilitation Biofeedback Therapy Device Market Size (2021-2032) & (US$ Million) Figure 7. Global Neurorehabilitation Biofeedback Therapy Device Sales (2021-2032) & (Units) Figure 8. Global Neurorehabilitation Biofeedback Therapy Device Average Price (K US$/Unit) & (2021-2032) Figure 9. Conventional Product Image Figure 10. Intelligent Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Others Product Image Figure 14. Global Neurorehabilitation Biofeedback Therapy Device Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Neurorehabilitation Biofeedback Therapy Device, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Neurorehabilitation Biofeedback Therapy Device Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Neurorehabilitation Biofeedback Therapy Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Neurorehabilitation Biofeedback Therapy Device Sales by Region in 2025 Figure 20. Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region in 2025 Figure 21. North America Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 22. North America Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 23. North America Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 24. United States Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 28. Europe Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 29. Europe Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 30. Germany Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 41. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 43. China Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 52. South America Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 53. South America Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 54. Brazil Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Market Size by Country in 2025 Figure 58. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Country (2021-2032) Figure 60. Egypt Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Neurorehabilitation Biofeedback Therapy Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2032) Figure 66. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2032) Figure 67. Global Neurorehabilitation Biofeedback Therapy Device Price (K US$/Unit) by Type (2021-2032) Figure 68. Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2032) Figure 69. Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2032) Figure 70. Global Neurorehabilitation Biofeedback Therapy Device Price (K US$/Unit) by Application (2021-2032) Figure 71. Neurorehabilitation Biofeedback Therapy Device Value Chain Figure 72. Neurorehabilitation Biofeedback Therapy Device Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Neurorehabilitation Biofeedback Therapy Device Industry Opportunities and Challenges

Scope & coverage.

Types
  • Conventional
  • Intelligent
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • ARKRAY
  • Ascensia
  • B. Braun
  • BIONIME
  • GMMC Group
  • LIANFA
  • Lifescan
  • Lobeck Medical AG
  • Sinocare
  • TERUMO
  • Roche

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Neurorehabilitation Biofeedback Therapy Device Market Size (2021-2032)
  4. 2.2.2 Global Neurorehabilitation Biofeedback Therapy Device Sales (2021-2032)
  5. 2.2.3 Global Neurorehabilitation Biofeedback Therapy Device Market Average Price (2021-2032)
  6. 2.3 Neurorehabilitation Biofeedback Therapy Device by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Conventional
  9. 2.3.3 Intelligent
  10. 2.4 Neurorehabilitation Biofeedback Therapy Device by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Neurorehabilitation Biofeedback Therapy Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Neurorehabilitation Biofeedback Therapy Device Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Neurorehabilitation Biofeedback Therapy Device Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Neurorehabilitation Biofeedback Therapy Device Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Neurorehabilitation Biofeedback Therapy Device, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Neurorehabilitation Biofeedback Therapy Device, Product Type & Application
  8. 3.8 Global Manufacturers of Neurorehabilitation Biofeedback Therapy Device, Established Date
  9. 3.9 Global Neurorehabilitation Biofeedback Therapy Device Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Company Information
  3. 4.1.2 Abbott Business Overview
  4. 4.1.3 Abbott Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 ARKRAY
  8. 4.2.1 ARKRAY Company Information
  9. 4.2.2 ARKRAY Business Overview
  10. 4.2.3 ARKRAY Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ARKRAY Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  12. 4.2.5 ARKRAY Recent Developments
  13. 4.3 Ascensia
  14. 4.3.1 Ascensia Company Information
  15. 4.3.2 Ascensia Business Overview
  16. 4.3.3 Ascensia Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Ascensia Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  18. 4.3.5 Ascensia Recent Developments
  19. 4.4 B. Braun
  20. 4.4.1 B. Braun Company Information
  21. 4.4.2 B. Braun Business Overview
  22. 4.4.3 B. Braun Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 B. Braun Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  24. 4.4.5 B. Braun Recent Developments
  25. 4.5 BIONIME
  26. 4.5.1 BIONIME Company Information
  27. 4.5.2 BIONIME Business Overview
  28. 4.5.3 BIONIME Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 BIONIME Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  30. 4.5.5 BIONIME Recent Developments
  31. 4.6 GMMC Group
  32. 4.6.1 GMMC Group Company Information
  33. 4.6.2 GMMC Group Business Overview
  34. 4.6.3 GMMC Group Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GMMC Group Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  36. 4.6.5 GMMC Group Recent Developments
  37. 4.7 LIANFA
  38. 4.7.1 LIANFA Company Information
  39. 4.7.2 LIANFA Business Overview
  40. 4.7.3 LIANFA Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 LIANFA Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  42. 4.7.5 LIANFA Recent Developments
  43. 4.8 Lifescan
  44. 4.8.1 Lifescan Company Information
  45. 4.8.2 Lifescan Business Overview
  46. 4.8.3 Lifescan Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lifescan Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  48. 4.8.5 Lifescan Recent Developments
  49. 4.9 Lobeck Medical AG
  50. 4.9.1 Lobeck Medical AG Company Information
  51. 4.9.2 Lobeck Medical AG Business Overview
  52. 4.9.3 Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Lobeck Medical AG Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  54. 4.9.5 Lobeck Medical AG Recent Developments
  55. 4.10 Sinocare
  56. 4.10.1 Sinocare Company Information
  57. 4.10.2 Sinocare Business Overview
  58. 4.10.3 Sinocare Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sinocare Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  60. 4.10.5 Sinocare Recent Developments
  61. 4.11 TERUMO
  62. 4.11.1 TERUMO Company Information
  63. 4.11.2 TERUMO Business Overview
  64. 4.11.3 TERUMO Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 TERUMO Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  66. 4.11.5 TERUMO Recent Developments
  67. 4.12 Roche
  68. 4.12.1 Roche Company Information
  69. 4.12.2 Roche Business Overview
  70. 4.12.3 Roche Neurorehabilitation Biofeedback Therapy Device Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Roche Neurorehabilitation Biofeedback Therapy Device Product Portfolio
  72. 4.12.5 Roche Recent Developments
5 Global Neurorehabilitation Biofeedback Therapy Device Market Scenario by Region
  1. 5.1 Global Neurorehabilitation Biofeedback Therapy Device Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2021-2032
  3. 5.2.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2021-2026
  4. 5.2.2 Global Neurorehabilitation Biofeedback Therapy Device Sales by Region: 2027-2032
  5. 5.3 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2021-2032
  6. 5.3.1 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2021-2026
  7. 5.3.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Region: 2027-2032
  8. 5.4 North America Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  9. 5.4.1 North America Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  11. 5.4.3 North America Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  16. 5.5.1 Europe Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  18. 5.5.3 Europe Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  41. 5.7.1 South America Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  43. 5.7.3 South America Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Neurorehabilitation Biofeedback Therapy Device Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032)
  2. 6.1.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Type (2021-2032)
  4. 6.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Type (2021-2032)
  5. 6.2.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Neurorehabilitation Biofeedback Therapy Device Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032)
  2. 7.1.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Neurorehabilitation Biofeedback Therapy Device Sales Market Share by Application (2021-2032)
  4. 7.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue by Application (2021-2032)
  5. 7.2.1 Global Neurorehabilitation Biofeedback Therapy Device Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Neurorehabilitation Biofeedback Therapy Device Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Neurorehabilitation Biofeedback Therapy Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Neurorehabilitation Biofeedback Therapy Device Value Chain Analysis
  2. 8.1.1 Neurorehabilitation Biofeedback Therapy Device Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Neurorehabilitation Biofeedback Therapy Device Production Mode & Process
  5. 8.2 Neurorehabilitation Biofeedback Therapy Device Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Neurorehabilitation Biofeedback Therapy Device Distributors
  8. 8.2.3 Neurorehabilitation Biofeedback Therapy Device Customers
9 Global Neurorehabilitation Biofeedback Therapy Device Analyzing Market Dynamics
  1. 9.1 Neurorehabilitation Biofeedback Therapy Device Industry Trends
  2. 9.2 Neurorehabilitation Biofeedback Therapy Device Industry Drivers
  3. 9.3 Neurorehabilitation Biofeedback Therapy Device Industry Opportunities and Challenges
  4. 9.4 Neurorehabilitation Biofeedback Therapy Device Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst